UNITED
STATES


SECURITIES
AND EXCHANGE COMMISSION


Washington,
D.C. 20549




______________






FORM
10-Q




______________







[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934





For
the quarter ended March 31, 2010





[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934





For
the transition period from ____________ to____________





Commission
File Number: 000-53373





RxBids


(Exact
name of issuer as specified in its charter)





Nevada
            20-1226081(State
      or Other Jurisdiction of
            (I.R.S.
      Employer Identification No.)incorporation
      or organization)





9050 W.
Warm Springs Rd #12-2129


Las Vegas, Nevada
89148


(Address
of principal executive offices)





(702)
540-2222


(Registrant's
telephone number, including area code)





Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
past 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days.


Yes  [X]   No  [  ]





Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such
files).Yes  [  ]    No  [   ]





Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company.





Large
      accelerated filer [  ]
            Accelerated
      filer [  ]
            Non-accelerated
      filer [  ]
            Smaller
      reporting company [X]


(Do not
check if a smaller reporting company)





Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).


Yes  [  ]   No[X]


1








APPLICABLE
ONLY TO CORPORATE ISSUERS





Indicate
the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.





Class
            
            Outstanding
      as of May 6, 2010Common
      Stock, $.01 par value
            
            5,274,400











2


TABLE
OF CONTENTS





Heading
            Page





PART  I    —   FINANCIAL
      INFORMATION





Item
      1.
            Financial
      Statements
            4Item
      2.
            Management's
      Discussion and Analysis of Financial Condition and Results of
      Operations
            10Item
      3.
            Quantitative
      and Qualitative Disclosures About Market Risk
            11Item
      4(T).
            Controls
      and Procedures
            11





PART  II    —   OTHER
      INFORMATION





Item
      1.
            Legal
      Proceedings
            12Item
      1A.
            Risk
      Factors
            12Item
      2.
            Unregistered
      Sales of Equity Securities and Use of Proceeds
            12Item
      3.
            Defaults
      Upon Senior Securities
            12Item
      4.
            Submission
      of Matters to a Vote of Securities Holders
            12Item
      5.
            Other
      Information
            12Item
      6.
            Exhibits
            12Signatures
            13

















3


PART  I   —   FINANCIAL
INFORMATION





Item
1.  Financial Statements





The
accompanying unaudited balance sheet of RxBids at March 31, 2010 and related
unaudited statements of operations, and cash flows for the three months ended
March 31, 2010 and 2009 and the period from June 18, 2004 (date of inception)
through March 31, 2010, have been prepared by management in conformity with
United States generally accepted accounting principles.  In the
opinion of management, all adjustments considered necessary for a fair
presentation of the results of operations and financial position have been
included and all such adjustments are of a normal recurring
nature.  It is suggested that these financial statements be read in
conjunction with the financial statements and notes thereto included in the
RxBids December 31, 2009 audited financial statements.  Operating
results for the period ended March 31, 2010, are not necessarily indicative of
the results that can be expected for the fiscal year ending December 31, 2010 or
any other subsequent period.





4


RxBids


(A
Development Stage Company)


Balance
Sheets








ASSETSMarch
      31,
            
            
            December
      31,2010
            
            
            2009CURRENT
      ASSETSCash
      and cash equivalents
            
            $
            1,999
            
            
            $
            954Total
      Current Assets
            
            
            1,999
            
            
            
            954EQUIPMENT,
      NET
            
            
            -
            
            
            
            -TOTAL
      ASSETS
            
            $
            1,999
            
            
            $
            954LIABILITIES AND STOCKHOLDERS' EQUITY
      (DEFICIT)CURRENT
      LIABILITIESAccounts
      payable and accrued expenses
            
            $
            31,545
            
            
            $
            32,757Payable
      - related party
            
            
            78,300
            
            
            
            69,600Total
      Current Liabilities
            
            
            109,845
            
            
            
            102,357STOCKHOLDERS'
      EQUITY (DEFICIT)Common
      stock; 20,000,000 sharesauthorized
      at $0.01 par value, 5,274,400shares
      issued and outstanding
            
            
            52,744
            
            
            
            52,744Additional
      paid-in capital
            
            
            502,488
            
            
            
            502,488Deficit
      accumulated during the development stage
            
            
            (663,078
            )
            
            
            (656,635
            )Total
      Stockholders' Equity (Deficit)
            
            
            (107,846
            )
            
            
            (101,403
            )TOTAL
      LIABILITIES ANDSTOCKHOLDERS'
      EQUITY (DEFICIT)
            
            $
            1,999
            
            
            $
            954








The
accompanying notes are an integral part of these financial
statements.


5





RxBids


(A
Development Stage Company)


Statements
of Operations





From
      Inception onJune
      18,For
      the Three Months Ended
            
            
            2004
      ThroughMarch
      31,
            
            
            March
      31,2010
            
            
            2009
            
            
            2010REVENUES
            
            $
            399
            
            
            $
            -
            
            
            $
            1,778COST
      OF SALES
            
            
            -
            
            
            
            -
            
            
            
            -GROSS
      MARGIN
            
            
            399
            
            
            
            -
            
            
            
            1,778OPERATING
      EXPENSESDepreciation
      expense
            
            
            -
            
            
            
            55
            
            
            
            1,100Sales
      and marketing
            
            
            994
            
            
            
            2,172
            
            
            
            45,854Research
      and development
            
            
            -
            
            
            
            -
            
            
            
            155,325Professional
      fees
            
            
            4,425
            
            
            
            3,234
            
            
            
            152,609General
      and administrative
            
            
            690
            
            
            
            2,475
            
            
            
            306,842Total
      Operating Expenses
            
            
            6,109
            
            
            
            7,936
            
            
            
            661,730LOSS FROM
      OPERATIONS
            
            
            (5,710
            )
            
            
            (7,936
            )
            
            
            (659,952
            )OTHER
      INCOME (EXPENSE)Interest
      Income (Expense)
            
            
            (733
            )
            
            
            -
            
            
            
            (3,126
            )Total
      Other Income(Expense)
            
            
            (733
            )
            
            
            -
            
            
            
            (3,126
            )LOSS
      BEFORE INCOME TAXES
            
            
            (6,443
            )
            
            
            (7,936
            )
            
            
            (663,078
            )INCOME
      TAX EXPENSE
            
            
            -
            
            
            
            -
            
            
            
            -NET
      LOSS
            
            $
            (6,443
            )
            
            $
            (7,936
            )
            
            $
            (663,078
            )BASIC
      AND DILUTEDLOSS
      PER SHARE
            
            $
            (0.00
            )
            
            $
            (0.00
            )WEIGHTED
      AVERAGE NUMBEROF
      SHARES OUTSTANDING
            
            
            5,274,400
            
            
            
            5,274,400





The
accompanying notes are an integral part of these financial
statements.


6


RxBids


(A
Development Stage Company)


Statements
of Cash Flows


From
      Inception onJune
      18, 2004For
      the Three Months Ended
            
            
            ThroughMarch
      31,
            
            
            March
      31,2010
            
            
            2009
            
            
            2010OPERATING
      ACTIVITIESNet
      loss
            
            $
            (6,443
            )
            
            $
            (7,936
            )
            
            $
            (663,078
            )Adjustments
      to reconcile net loss to net cash used by operating
      activities:Common
      stock issued for services
            
            
            -
            
            
            
            -
            
            
            
            50,000Depreciation
      and amortization
            
            
            -
            
            
            
            55
            
            
            
            1,100Changes
      in operating assets and liabilities:Change
      in accounts payable
            
            
            (1,212
            )
            
            
            (2,649
            )
            
            
            31,545Net
      Cash Used inOperating
      Activities
            
            
            (7,655
            )
            
            
            (10,530
            )
            
            
            (580,433
            )INVESTING
      ACTIVITIESPurchase
      of property and equipment
            
            
            -
            
            
            
            -
            
            
            
            (1,100
            )Net
      Cash Used in Investing Activities
            
            
            -
            
            
            
            -
            
            
            
            (1,100
            )FINANCING
      ACTIVITIESProceeds
      from related party loans and advances
            
            
            8,700
            
            
            
            10,537
            
            
            
            410,932Proceeds
      from common stock issued
            
            
            -
            
            
            
            -
            
            
            
            172,600Net
      Cash Provided by Financing Activities
            
            
            8,700
            
            
            
            10,537
            
            
            
            583,532NET
      DECREASE IN CASH
            
            
            1,045
            
            
            
            7
            
            
            
            1,999CASH
      AT BEGINNING OF PERIOD
            
            
            954
            
            
            
            678
            
            
            
            -CASH
      AT END OF PERIOD
            
            $
            1,999
            
            
            $
            685
            
            
            $
            1,999SUPPLEMENTAL
      DISCLOSURES OF CASH FLOW INFORMATIONCASH
      PAID FOR:Interest
            
            $
            -
            
            
            $
            -
            
            
            $
            -Income
      Taxes
            
            $
            -
            
            
            $
            -
            
            
            $
            -NON-CASH
      FINANCING ACTIVITIES:Common
      stock issued for services
            
            $
            -
            
            
            $
            50,000
            
            
            $
            50,000Common
      stock issued for debt
            
            $
            -
            
            
            $
            -
            
            
            $
            332,632




7


RxBids


(A
Development Stage Company)


Notes
to Financial Statements


(Unaudited)





NOTE
1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES





The
accompanying financial statements have been prepared by the Company without
audit.  In the opinion of management, all adjustments (which include
only normal recurring adjustments) necessary to present fairly the financial
position, results of operations, and cash flows at March 31, 2010, and for all
periods presented herein, have been made.





Certain
information and footnote disclosures normally included in financial statements
prepared in accordance with accounting principles generally accepted in the
United States of America have been condensed or omitted.  It is
suggested that these condensed financial statements be read in conjunction with
the financial statements and notes thereto included in the Company's September
30, 2009 audited financial statements.  The results of operations for
the period ended March 31, 2010 is not necessarily indicative of the operating
results for the full year.





NOTE
2 - GOING CONCERN





The
Company's financial statements are prepared using generally accepted accounting
principles in the United States of America applicable to a going concern which
contemplates the realization of assets and liquidation of liabilities in the
normal course of business. The Company has not yet established an ongoing source
of revenues sufficient to cover its operating costs and allow it to continue as
a going concern. The ability of the Company to continue as a going concern is
dependent on the Company obtaining adequate capital to fund operating losses
until it becomes profitable. If the Company is unable to obtain adequate
capital, it could be forced to cease operations.





In order
to continue as a going concern, the Company will need, among other things,
additional capital resources. Management's plan is to obtain such resources for
the Company by obtaining capital from management and significant shareholders
sufficient to meet its minimal operating expenses and seeking equity and/or debt
financing. However management cannot provide any assurances that the Company
will be successful in accomplishing any of its plans.





The
ability of the Company to continue as a going concern is dependent upon its
ability to successfully accomplish the plans described in the preceding
paragraph and eventually secure other sources of financing and attain profitable
operations. The accompanying financial statements do not include any adjustments
that might be necessary if the Company is unable to continue as a going
concern.





NOTE
3 – SIGNIFICANT ACCOUNTING POLICIES





Use of
Estimates





The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities at the date of the financial statements and the reported amounts of
revenue and expenses during the reporting period. Actual results could differ
from those estimates.





Recent Accounting
Pronouncements





In
January 2010, the FASB issued Accounting Standards Update 2010-02, Consolidation
(Topic 810): Accounting and Reporting for Decreases in Ownership of a
Subsidiary. This amendment to Topic 810 clarifies, but does not change, the
scope of current US GAAP. It clarifies the decrease in ownership provisions of
Subtopic 810-10 and removes the potential conflict between guidance in that
Subtopic and asset de-recognition and gain or loss recognition guidance that may
exist in other US GAAP. An entity will be required to follow the amended
guidance beginning in the period that it first adopts FAS 160 (now included in
Subtopic 810-10). For those entities that have





8


already
adopted FAS 160, the amendments are effective at the beginning of the first
interim or annual reporting period ending on or after December 15, 2009. The
amendments should be applied retrospectively to the first period that an entity
adopted FAS 160. The Company does not expect the provisions of ASU 2010-02 to
have a material effect on the financial position, results of operations or cash
flows of the Company.





In
January 2010, the FASB issued Accounting Standards Update 2010-01, Equity (Topic
505): Accounting for Distributions to Shareholders with Components of Stock and
Cash (A Consensus of the FASB Emerging Issues Task Force). This amendment to
Topic 505 clarifies the stock portion of a distribution to shareholders that
allows them to elect to receive cash or stock with a limit on the amount of cash
that will be distributed is not a stock dividend for purposes of applying Topics
505 and 260. Effective for interim and annual periods ending on or after
December 15, 2009, and would be applied on a retrospective basis. The Company
does not expect the provisions of ASU 2010-01 to have a material effect on the
financial position, results of operations or cash flows of the
Company.





NOTE
4 - RELATED PARTY TRANSACTIONS





From its
inception through December 28, 2006, the Company received $332,632 in loans from
shareholders.  On December 28, 2006, the Company issued 4,000,000
shares of its common stock in satisfaction of those loans.





Through
the March 31, 2010 the Company has received cash advances from a shareholder and
officer of $78,300. The advances are unsecured, non interest bearing and due
upon demand.





NOTE
5 – CAPITAL STOCK





The
Company has 20,000,000 common shares authorized at a par value of
$0.01.  As of December 31, 2009 the Company has 5,274,400 shares of
common stock issued and outstanding.  The following is a list of all
sales of common the Company’s common stock from inception through the year ended
December 31, 2009.





During
2006 the Company issued 4,480,000 shares of its common stock for cash at $0.05
per share. On January 18, 2007, the Company collected the $24,000 of stock
subscriptions receivable.





During
2007, the Company issued 414,400 shares of common stock for cash of $103,600 at
$0.25 per share.





During
2008, the Company issued 180,000 shares of common stock for cash of $45,000 and
200,000 shares for services valued at $50,000. The Company’s common stock was
issued at $0.25 per share.





NOTE
6 – SUBSEQUENT EVENTS





In
accordance with ASC 855-10 Company management reviewed all material events
through the date of this report and there are no material subsequent events to
report.





9





Item
2.  Management's Discussion and Analysis of Financial Condition and
Results of Operations





The
following information should be read in conjunction with the financial
statements and notes thereto appearing elsewhere in this Form 10-Q.





Liquidity
and Capital Resources





In
December 2007, we realized gross proceeds of $103,600 from the public offering
of our common stock.  We have used these proceeds to develop our
website and to commence advertising to promote and market our medical
prescription auction service.  At March 31, 2010, we had available
cash of $1,999 compared to $954 at December 31, 2009.  We are
currently being funded by loans from our President, Mack Bradley.  Mr.
Bradley has indicated that he will avail his personal financial resources to the
company on an as needed basis until such a time that we can procure additional
financing.  We are currently exploring the possibility of additional
alternative financing, but there is no assurance that we will be able to secure
financing on favorable terms or at all.





At March
31, 2010, we had total current assets of $1,999 in cash and total current
liabilities of $109,854, consisting of accounts payable and accrued expenses of
$31,545 and a payable to related party of $78,300.  At December 31,
2009, we had total current assets of $954 in cash and total current liabilities
of $102,357, consisting of accounts payable and accrued expenses of $32,757 and
a payable to related party of $69,600.  Working capital at March 31,
2010 was a negative $107,846 compared to $101,403 at December 31,
2009.  This decrease in working capital for the first three months of
2010 is primarily due to the 13% increase in the payable to related party, which
represents additional borrowing during the period.  At March 31, 2010,
we had total assets of $1,999 and a stockholders’ deficit of $107,846, compared
to total assets of $954 and a stockholders' deficit of $101,403 at December 31,
2009.





Net cash
used by operating activities was $7,655 for the first three months of 2010
compared to $10,530 for the comparable 2009 period.  This result is
primarily attributed to the decreased net loss from $7,936 for the 2009 period,
compared to $6,443 for the 2010 period.  Also during the first three
months of 2010, we realized $8,700 in proceeds from related party loans compared
to $10,537 for the 2009 period.





Results
of Operations





We
realized $399 in revenues for the three-month period (“first quarter”) ended
March 31, 2010 compared to $0 revenues for the first quarter of
2009.  Total operating expenses for the first quarter of 2010 were
$6,109, a 23% decrease from $7,936 for the first quarter of 2009.  The
decrease is primarily attributed to the 54% decrease in sales and marketing
expenses from $2,172 in 2009 to $994 in 2010, due to decreased marketing
efforts, and the 72% decrease in general and administrative expenses, from
$2,475 in 2009 to $690 in 2010, due to out sourcing server requirement and
decreased staffing.  The decrease was partially offset by the 37%
decrease in professional fees from $3,234 in 2009 to $4,425 in 2010 related to
the expense of preparing and filing our requisite SEC reports.  Our
net loss was $6,443 for the first quarter of 2010 compared to $7,936 for the
first quarter of 2009.





In the
opinion of management, inflation has not and will not have a material effect on
our operations in the immediate future.  Management will continue to
monitor inflation and evaluate the possible future effects of inflation on our
business and operations.





Net
Operating Loss





The
Company has accumulated approximately $603,604  of net operating loss
carryforward at December 31, 2009.  This loss carryforward may be
offset against future taxable income through the year 2029.  The use
of these losses to reduce future income taxes will depend on the generation of
sufficient taxable income prior to the expiration of the net operating loss
carryforwards.  In the event of certain changes in control, there will
be an annual limitation on the amount of net operating loss carryforwards that
can be used.  No tax benefit has been reported in the financial
statements for the year ended December 31, 2009 or three month period ended
March 31, 2010 because it has been fully offset by a valuation
allowance.


10





Inflation





In the
opinion of management, inflation has not and will not have a material effect on
our operations in the immediate future.  Management will continue to
monitor inflation and evaluate the possible future effects of inflation on our
business and operations.





Off-balance
Sheet Arrangements





We have
no off-balance sheet arrangements.





Forward-Looking
and Cautionary Statements





This
report includes "forward-looking statements" that may relate to such matters as
anticipated financial performance, future revenues or earnings, business
prospects, projected ventures, new products and services, anticipated market
performance and similar matters.





When used
in this report, the words "may," "will," expect," anticipate," "continue,"
"estimate," "project," "intend," and similar expressions are intended to
identify forward-looking statements regarding events, conditions, and financial
trends that may affect our future plans of operations, business strategy,
operating results, and financial position.





We
caution readers that a variety of factors could cause our actual results to
differ materially from the anticipated results or other matters expressed in
forward-looking statements. These risks and uncertainties, many of which are
beyond our control, include:





●
            the
      sufficiency of existing capital resources and the ability to raise
      additional capital to fund cash requirements for future
      operations;●
            the
      ability to successfully operate our website and generate a sufficient
      number of consumers and pharmacies to purchase their medications from
      RxBIDS.com and the ability to broaden our pharmaceutical
      network;●
            volatility
      of the stock market, particularly within the online medical prescription
      sector; and●
            general
      economic conditions.





Although
we believe the expectations reflected in these forward-looking statements are
reasonable, such expectations cannot guarantee future results, levels of
activity, performance or achievements.





Item
3.  Quantitative and Qualitative Disclosures About Market
Risk.





This item
is not required for a smaller reporting company.





Item
4(T).  Controls and Procedures.





Evaluation of Disclosure Controls
and Procedures.  Disclosure controls and procedures (as defined
in Rules  13a-15(e) and 15d-15(e) under the Securities Exchange Act of
1934) are designed to ensure that information required to be disclosed in
reports filed or submitted under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in SEC rules and
forms.  Disclosure and control procedures are also designed to ensure
that such information is accumulated and communicated to management, including
the chief executive officer and principal accounting officer, to allow timely
decisions regarding required disclosures.





As of the
end of the period covered by this quarterly report, we carried out an
evaluation, under the supervision and with the participation of management,
including our chief executive officer and principal accounting officer, of the
effectiveness of the design and operation of our disclosure controls and
procedures.  In designing and evaluating the disclosure controls and
procedures, management recognizes that there are inherent limitations to the
effectiveness of any system of disclosure controls and procedures, including the
possibility of human error and the circumvention or overriding of the controls
and procedures.  Accordingly, even effective disclosure controls and
procedures can only


11





provide
reasonable assurance of achieving their desired control
objectives.  Additionally, in evaluating and implementing possible
controls and procedures, management is required to apply its reasonable
judgment.  Based on the evaluation described above, our management,
including our principal executive officer and principal accounting officer, have
concluded that, as of March 31, 2010, our disclosure controls and procedures
were not effective due to a lack of adequate segregation of duties and the
absence of an audit committee.





Changes in Internal Control Over
Financial Reporting.  Management has evaluated whether any
change in our internal control over financial reporting occurred during the
first quarter of fiscal 2010. Based on its evaluation, management, including the
chief executive officer and principal accounting officer, has concluded that
there has been no change in our internal control over financial reporting during
the first quarter of fiscal 2010 that has materially affected, or is reasonably
likely to materially affect, our internal control over financial
reporting.





PART  II   —   OTHER
INFORMATION





Item
1.  Legal Proceedings





There are
no material pending legal proceedings to which we are a party or to which any of
our property is subject and, to the best of our knowledge, no such actions
against us are contemplated or threatened.





Item
1A.  Risk Factors





This item
is not required for a smaller reporting company.





Item
2.  Unregistered Sales of Equity Securities and Use of
Proceeds





This Item
is not applicable.





Item
3.  Defaults Upon Senior Securities





This Item
is not applicable.





Item
4.  Submission of Matters to a Vote of Security Holders





This Item
is not applicable.





Item
5.  Other Information





This Item
is not applicable.





Item
6.  Exhibits





12








SIGNATURES





Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.





RxBids





Date:
            05/13/10
            
            By:
            /s/Mack
      BradleyMack
      Bradley, CEO and Director(Acting
      Principal Accounting Officer)